Comparação entre as medidas da espessura da camada de fibras nervosas da retina e da mácula pela tomografia de coerência óptica na detecção da perda axonal progressiva decorrente à neuropatia óptica traumática

PURPOSE: To compare the optical coherence tomography retinal nerve fiber layer and macular thickness measurements for detection of progressive axonal loss following acute traumatic optic neuropathy in a longitudinal study. METHODS: Three patients with unilateral traumatic optic neuropathy were evaluated sequentially after trauma. Macular and retinal nerve fiber layer thickness measurements were obtained using optical coherence tomography weekly for five weeks and around the twelfth week after trauma. RESULTS: All patients showed progressive macular and retinal nerve fiber layer thickness reduction. The mean retinal nerve fiber layer thickness on the first week was 114 μm and reduced sequentially over the first five weeks and was 46 μm on the twelfth week. For macular parameters, the mean average thickness on the first week was 248 μm and also reduced over the first five weeks and was 218 μm on the twelfth week. When compared to the initial measurement, macular thickness average reduction rate at the 12th week was 14% while peripapillary retinal nerve fiber layer thickness average reduction rate was 59%. CONCLUSIONS: Although both measurements reduce significantly after trauma, retinal nerve fiber layer thickness measurements show greater and faster retinal neural reduction if compared to macular thickness measurements in traumatic optic neuropathy.OBJETIVO: Comparar as medidas da espessura da camada de fibras nervosas da retina e macular obtidas pela tomografia de coerência óptica na detecção da perda axonal progressiva após neuropatia óptica traumática aguda e durante o seguimento clínico. MÉTODOS: Três pacientes com neuropatia óptica traumática unilateral aguda foram avaliados sequencialmente após o trauma. Medidas da espessura macular e da camada de fibras nervosas da retina foram obtidas pela tomografia de coerência óptica semanalmente por 5 semanas consecutivas e ao redor da décima segunda semana após o trauma. RESULTADOS: Todos os pacientes apresentaram redução progressiva dos valores da espessura macular e da camada de fibras nervosas da retina. A espessura média da camada de fibras nervosas da retina foi de 114 μm na primeira semana e reduziu sequencialmente ao longo das primeiras cinco semanas e foi de 46 μm na décima segunda semana. Para parâmetros macular, a espessura média foi de 248 μm na primeira semana, e também reduziu ao longo das primeiras cinco semanas e foi de 218 μm na décima segunda semana. Quando comparado às medidas iniciais, a taxa de redução das médias da espessura macular foi 14% na décima segunda semana após o trauma, enquanto que a taxa de redução das médias da espessura da camada de fibras nervosas da retina foi 59%. CONCLUSÕES: Os valores da espessura da camada de fibras nervosas da retina apresentaram uma redução maior e mais rápida se comparada às medidas da espessura macular na neuropatia óptica traumática

Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

Summary Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung’s disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung’s disease) from 264 hospitals (89 in high-income countries, 166 in middleincome countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in lowincome countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between lowincome, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030

Correlation between macular and retinal nerve fiber layer Fourier domain and time domain optical coherence tomography measurements and visual field loss in band atrophy of the optic nerve

OBJETIVO: Investigar a correlação entre as espessuras da mácula e da camada de fibras nervosas da retina (CFNR), medidas pelas tomografias de coerência óptica de domínio Fourier (FD - OCT) e de domínio do tempo (TD - OCT) e a perda de sensibilidade no campo visual (CV) em pacientes com atrofia em banda do nervo óptico. Comparar a habilidade diagnóstica dos dois instrumentos. MÉTODOS: 36 olhos de 36 pacientes com perda de CV permanente por compressão do quiasma óptico e 36 controles normais foram submetidos ao exame de CV pela perimetria automatizada padrão (Humphrey Field Analyzer TM; Carl Zeiss Meditec, Dublin, CA), ao FD - OCT (3 D OCT-1000TM Topcon Corp., Tokyo, Japan) e ao TD - OCT (StratusTM ;Carl Zeiss Meditec Inc, Dublin, California, USA). Foram comparados os protocolos análogos de ambos os equipamentos para avaliação da espessura macular.Foi realizado a divisão macular em quatro quadrantes e em metades, sendo calculado a média da espessura macular global, a média da espessura dos quadrantes e a média da espessura das metades maculares. A média global e setorial da medida da espessura da CFNR peripapilar também foi analisada. A perda de sensibilidade no CV foi inicialmente avaliada pelo defeito temporal médio. O CV foi ainda dividido em 6 setores de acordo com a distribuição da CFNR e em 16 pontos centrais para a realização da correlação estrutura-função entre os parâmetros medidos pelo FD - OCT e a perda de sensibilidade no CV em decibéis e 1/Lambert. Foi calculado o coeficiente de correlação de Sperman e a análise de regressão linear. As áreas sobre a curva ROC e valores fixos de sensibilidade e especificidade foram calculados para cada parâmetro estudado. RESULTADOS: As medidas da espessura macular e da CFNR pelo FD - OCT e TD - OCT foram capazes de discriminar olhos com atrofia em banda do nervo óptico dos controles normais. A espessura global e setorial dos parâmetros maculares e da CFNR mostraram diferenças significativas (p<0,001) entre os doentes e os controles e os dois aparelhos tiveram desempenho semelhante na discriminação entre pacientes e controles. Em ambos existiram correlações significativas entre a perda de sensibilidade do CV e as medidas da espessura macular e da CFNR. As medidas de espessura nos quadrantes e nas metades nasais da macula, avaliadas pelo FD - OCT tiveram os melhores desempenhos nas correlações com os defeitos de CV, sendo o parâmetro com a melhor correlação, a medida do quadrante infero-nasal da mácula e a perda de sensibilidade do CV central do quadrante temporal superior central (r = 0.78, R2 = 61%, p<0,001). CONCLUSÕES: A espessura macular e a espessura da CFNR medidas pelo FD - OCT e pelo TD - OCT se correlacionaram topograficamente com a perda de sensibilidade no CV de pacientes com hemianopsia temporal por compressäo quiasmática. A correlação entre os quadrantes maculares e a perda de sensibilidade no CV, foram melhores do que aquelas entre o CV e as medidas da CFNR, principalmente nas medidas realizadas pelo FD - OCT. Este estudo demonstrou a importância clínica das medidas maculares na correlação estrutura-função e na quantificaçäo do dano neural em pacientes com compressão quiasmática, podendo ser útil na monitorização destes pacientesPURPOSE: To investigate the relationship between fourier-domain optical coherence tomography (FD - OCT) measured macular and retinal nerve fiber layer thickness (RNFL) and visual field sensitivity loss on standard automated perimetry in eyes with permanent temporal hemianopia from chiasmal compression and compare the ability of FD - OCT and time-domain optical coherence tomography (TD - OCT) to detect axonal loss in eyes with band atrophy of the optic nerve. METHODS: One eye of each of 36 patients with permanent temporal visual field defects and 36 age- and sex-matched healthy subjects. Subjects underwent standard automated perimetry and macular and RNFL thickness measurements with FD - OCT (3 D OCT-1000® Topcon Corp., Tokyo, Japan) and TD - OCT (Stratus; Carl Zeiss Meditec Inc, Dublin, California, USA). Macular thickness measurements as a global average, divided in four quadrants and in two halves as well as average and sectoral RNFL thickness around the optic disc were calculated. Visual field sensitivity loss was evaluated by the temporal mean defect; as deviations from normal in six sectors of the visual field and in 16 central visual field test points. Relationship between visual field sensitivity loss in decibel and 1/Lambert units and optical coherence tomography measurements were evaluated using Spearman correlation coefficients and by linear regression analysis. Receiver operating characteristic curves and sensitivities at fixed specificities were calculated for each parameter. RESULTS: Global and sectoral macular and RNFL thickness parameters showed a significant difference in eyes with band atrophy compared with controls. The strongest correlations were seen between visual field sensitivity loss and quadrantic or hemianopic nasal macular thickness measurements than with sectoral retinal nerve fiber layer thickness measurements. The highest correlation was observed between the inferonasal quadrant macular thickness and the visual field sensitivity loss in the superior temporal central visual field quadrant (r = 0.78, R2 = 61%, p <0.001). CONCLUSION: Both RNFL thickness and macular thickness FD - OCT and TD - OCT measurements were related topographically with visual field sensitivity loss in patients with temporal hemianopia from chiasmal compression and there is a stronger relationship in quadrantic macular compared to RNFL thickness measurements with FD - OCT. Macular thickness measurements could potentially be used to quantify neuronal loss in patients with chiasmal compression and could prove clinically useful for detection of damage and for monitoring these patient

Correlação entre defeito de campo visual e espessura macular quadrântica avaliada através da tomografia de coerência óptica em pacientes com compressão quiasmática

PURPOSE: To correlate visual field sensitivity (VFS) loss on standard automated perimetry (SAP) and quadrantic macular thickness on optical coherence tomography (OCT) in patients with permanent temporal hemianopia from chiasmal compression. METHODS: Forty eyes from 40 patients with chiasmal compression and 40 healthy eyes were submitted to standard automated perimetry and Stratus-OCT scanning. Raw data of the fast macular thickness scanning protocol were exported and macular thickness measurements were recorded and averaged for each quadrant and half of the central area. The correlation between visual field sensitivity loss and optical coherence tomography measurements was tested with Pearson's correlation coefficients and with linear regression analysis. RESULTS: A significant association was found between each macular thickness parameter and the corresponding central VF mean sensitivity. The strongest association was observed between superonasal macular thickness and the inferotemporal mean defect measured both in decibel (R=0.47; p=0.001) and in 1/Lambert (R=0.59; p<0.0001) units. CONCLUSION: Stratus-OCT-measured macular thickness was topographically related with visual field sensitivity loss in patients with temporal hemianopia from chiasmal compression. Such measurements could prove clinically useful in the diagnosis and follow-up of patients with chiasmal compression. ClinicalTrial.gov identifier number: NCT0039122.OBJETIVO: Avaliar a correlação entre o defeito de campo visual ao exame de perimetria computadorizada e a espessura macular quadrântica ao exame de tomografia de coerência óptica (OCT) em pacientes com hemianopsia temporal permanente causada por compressão quiasmática. MÉTODOS: Quarenta olhos de 40 pacientes com compressão quiasmática e 40 olhos de 40 indivíduos controles foram submetidos aos exames de perimetria computadorizada e tomografia de coerência óptica. Dados não processados foram exportados e as medidas de espessura macular foram calculadas para cada quadrante e metade da área macular central. A correlação entre o defeito campimétrico e as medidas de espessura macular foi avaliada por coeficiente de correlação de Pearson e por análise de regressão linear. RESULTADOS: Associação significante foi encontrada entre os parâmetros de espessura macular e seus respectivos defeitos campimétricos. A correlação mais forte foi encontrada entre o parâmetro espessura macular nasal superior e o defeito campimétrico médio temporal inferior medido em decibel (R=0,47; p=0,001) e em 1/Lambert (R=0,59; p<0,0001). CONCLUSÃO: Medidas de espessura macular avaliada através da tomografia de coerência óptica foi topograficamente relacionada ao defeito campimétrico em pacientes com hemianopsia temporal por compressão quiasmática. Estas medidas podem provar a importância clínica no diagnóstico e seguimento dos pacientes com compressão quiasmática. ClinicalTrial.gov identifier number: NCT0039122

Health-status outcomes with invasive or conservative care in coronary disease

BACKGROUND In the ISCHEMIA trial, an invasive strategy with angiographic assessment and revascularization did not reduce clinical events among patients with stable ischemic heart disease and moderate or severe ischemia. A secondary objective of the trial was to assess angina-related health status among these patients. METHODS We assessed angina-related symptoms, function, and quality of life with the Seattle Angina Questionnaire (SAQ) at randomization, at months 1.5, 3, and 6, and every 6 months thereafter in participants who had been randomly assigned to an invasive treatment strategy (2295 participants) or a conservative strategy (2322). Mixed-effects cumulative probability models within a Bayesian framework were used to estimate differences between the treatment groups. The primary outcome of this health-status analysis was the SAQ summary score (scores range from 0 to 100, with higher scores indicating better health status). All analyses were performed in the overall population and according to baseline angina frequency. RESULTS At baseline, 35% of patients reported having no angina in the previous month. SAQ summary scores increased in both treatment groups, with increases at 3, 12, and 36 months that were 4.1 points (95% credible interval, 3.2 to 5.0), 4.2 points (95% credible interval, 3.3 to 5.1), and 2.9 points (95% credible interval, 2.2 to 3.7) higher with the invasive strategy than with the conservative strategy. Differences were larger among participants who had more frequent angina at baseline (8.5 vs. 0.1 points at 3 months and 5.3 vs. 1.2 points at 36 months among participants with daily or weekly angina as compared with no angina). CONCLUSIONS In the overall trial population with moderate or severe ischemia, which included 35% of participants without angina at baseline, patients randomly assigned to the invasive strategy had greater improvement in angina-related health status than those assigned to the conservative strategy. The modest mean differences favoring the invasive strategy in the overall group reflected minimal differences among asymptomatic patients and larger differences among patients who had had angina at baseline

Initial invasive or conservative strategy for stable coronary disease

BACKGROUND Among patients with stable coronary disease and moderate or severe ischemia, whether clinical outcomes are better in those who receive an invasive intervention plus medical therapy than in those who receive medical therapy alone is uncertain. METHODS We randomly assigned 5179 patients with moderate or severe ischemia to an initial invasive strategy (angiography and revascularization when feasible) and medical therapy or to an initial conservative strategy of medical therapy alone and angiography if medical therapy failed. The primary outcome was a composite of death from cardiovascular causes, myocardial infarction, or hospitalization for unstable angina, heart failure, or resuscitated cardiac arrest. A key secondary outcome was death from cardiovascular causes or myocardial infarction. RESULTS Over a median of 3.2 years, 318 primary outcome events occurred in the invasive-strategy group and 352 occurred in the conservative-strategy group. At 6 months, the cumulative event rate was 5.3% in the invasive-strategy group and 3.4% in the conservative-strategy group (difference, 1.9 percentage points; 95% confidence interval [CI], 0.8 to 3.0); at 5 years, the cumulative event rate was 16.4% and 18.2%, respectively (difference, 121.8 percentage points; 95% CI, 124.7 to 1.0). Results were similar with respect to the key secondary outcome. The incidence of the primary outcome was sensitive to the definition of myocardial infarction; a secondary analysis yielded more procedural myocardial infarctions of uncertain clinical importance. There were 145 deaths in the invasive-strategy group and 144 deaths in the conservative-strategy group (hazard ratio, 1.05; 95% CI, 0.83 to 1.32). CONCLUSIONS Among patients with stable coronary disease and moderate or severe ischemia, we did not find evidence that an initial invasive strategy, as compared with an initial conservative strategy, reduced the risk of ischemic cardiovascular events or death from any cause over a median of 3.2 years. The trial findings were sensitive to the definition of myocardial infarction that was used